Antonio J Villatoro is a PhD in Veterinary Medicine from Córdoba University, master's degree in Business Administration and Numerary Academician of the Royal Academy of Veterinary Sciences of Eastern Andalusia.
He has authored more than 100 articles and book chapters.
Founder and director of ImmuneStem in Malaga, Spain, dedicated to Immunology and Cell Therapy, from which he currently develops his professional and research activity.
In the last decade, he has dedicated his activity to the knowledge and development of different clinical protocols with cell therapy, mainly with mesenchymal stem cells and their derivatives, such as secretome and exosomes, in the treatment of different complex pathologies including immune-mediated and oncological diseases in the field of Veterinary Medicine.
As a result of his work is the translation of the results in veterinary patients as preclinic models for human medicine, in which he collaborates developing strategies with the use of mesenchymal stem cells in pathologies with high prevalence in humans, such as dry eye, diabetic ulcers, sepsis and a clinical trial in knee osteoarthritis, among others.
He currently collaborates as a researcher at the Bioengineering Laboratory and Tissue Regeneration (LABRET-UMA) from the Faculty of Sciences of the University of Malaga.
Member of the Cellular Therapy Network (TerCel), a multidisciplinary collaborative project that began its activity under Spain Government with the aim of promoting the therapeutic potential of stem cells and other advanced therapies in humans.